0001829522-26-000003.txt : 20260605 0001829522-26-000003.hdr.sgml : 20260605 20260604202920 ACCESSION NUMBER: 0001829522-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260605 DATE AS OF CHANGE: 20260604 EFFECTIVENESS DATE: 20260605 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Antlia Bioscience, Inc. CENTRAL INDEX KEY: 0001829522 ORGANIZATION NAME: EIN: 844808002 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-586295 FILM NUMBER: 261066625 BUSINESS ADDRESS: STREET 1: 1281 HYMETTUS AVE CITY: ENCINITAS STATE: CA ZIP: 92024 BUSINESS PHONE: 619-990-0290 MAIL ADDRESS: STREET 1: 1281 HYMETTUS AVE CITY: ENCINITAS STATE: CA ZIP: 92024 D 1 primary_doc.xml X0708 D LIVE 0001829522 Antlia Bioscience, Inc. 1281 HYMETTUS AVE ENCINITAS CA CALIFORNIA 92024 619-990-0290 DELAWARE None None Corporation true Ankit Mahadevia 1281 Hymettus Ave. Encinitas CA CALIFORNIA 92024 Executive Officer Director Ben Auspitz 1281 Hymettus Ave. Encinitas CA CALIFORNIA 92024 Director Brian Laurence Johnson 1281 Hymettus Ave. Encinitas CA CALIFORNIA 92024 Executive Officer Director Carlos Garcia Echeverria 1281 Hymettus Ave. Encinitas CA CALIFORNIA 92024 Director Nihal Sinha 1281 Hymettus Ave. Encinitas CA CALIFORNIA 92024 Director Martin Taylor 1281 Hymettus Ave. Encinitas CA CALIFORNIA 92024 Director Biotechnology Decline to Disclose 06b false 2026-05-22 false true false 0 20000000 6000000 14000000 false 3 0 0 0 The gross proceeds of the offering will be used for operating expenses, working capital and other general corporate purposes. false Antlia Bioscience, Inc. Ankit Mahadevia Ankit Mahadevia Chief Executive Officer 2026-06-04